The Consortium includes 11 sites across the country that are focusing on several large cohort studies. One of these studies tracks individuals over the age of 50 with new onset diabetes, a patient population with an increased risk of developing pancreatic cancer. Read more . . .
A $2.4 million, five-year grant renewal of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer from the National Institutes of Health and National Institute of Diabetes and Digestive and Kidney Diseases will enable researchers at Baylor College of Medicine to study the role the microbiome could play in diagnosing these diseases at an earlier stage.